OTC Markets Group Welcomes Perimeter Medical Imaging AI, Inc. to OTCQX
Perimeter Medical Imaging AI Upgrade: Perimeter Medical Imaging AI, Inc. has successfully upgraded to the OTCQX® Best Market from the Pink® market, allowing for improved trading transparency and visibility for U.S. investors under the ticker symbol "PYNKF."
Company Overview and Technology: The company specializes in advanced imaging tools for cancer surgery, including the FDA-cleared S-Series OCT system and the investigational B-Series OCT with ImgAssist AI, aimed at enhancing surgical outcomes and addressing unmet medical needs.
Trade with 70% Backtested Accuracy
Analyst Views on PINK

No data
About the author


Event Announcement: The Small Cap Growth Virtual Investor Conference is scheduled for October 16, 2025, inviting individual and institutional investors to participate in live presentations and one-on-one meetings with company management at no cost.
Company Presentations: The conference will feature a diverse lineup of companies, including Crushmetric, Zapp Electric Vehicles, and Hillcrest Energy Technologies, with scheduled presentations throughout the day.
UnitedHealth Group's Performance: UnitedHealth Group faced challenges in 2023 with weak Q2 earnings and a lowered full-year outlook, but improvements are anticipated by 2026 due to cost reduction and operational efficiency efforts.
ETF Investment Opportunities: Investors can consider the Simplify Health Care ETF (PINK) and T. Rowe Price Health Care ETF (TMED) for diversified exposure to UNH stock, both of which have shown positive returns and strong buy ratings from analysts.

Market Reactions to Middle Eastern Conflict: The ongoing conflict in the Middle East is causing significant fluctuations in global markets, with oil prices surging and increased interest in ETFs related to energy, defense, inflation protection, and cybersecurity as investors seek to navigate geopolitical risks.
Emergence of "Crisis Alpha" Investments: Investors are shifting focus towards ETFs that provide exposure to sectors likely to benefit from market dislocations caused by crises, including supply chain resilience and volatility trading products, as tensions remain high and diplomatic resolutions appear uncertain.
Biohaven's Investment Agreement: Biohaven Ltd. has entered a $600 million investment agreement with Oberland Capital Management, structured through a non-dilutive Note Purchase Agreement, which will support clinical trials and commercialization of its drug, troriluzole, pending FDA approval.
Stock Performance: Following the announcement, Biohaven shares rose by 5.85% in premarket trading, reflecting positive investor sentiment regarding the funding and potential future developments related to the treatment for spinocerebellar ataxia.
Perimeter Medical Imaging AI Upgrade: Perimeter Medical Imaging AI, Inc. has successfully upgraded to the OTCQX® Best Market from the Pink® market, allowing for improved trading transparency and visibility for U.S. investors under the ticker symbol "PYNKF."
Company Overview and Technology: The company specializes in advanced imaging tools for cancer surgery, including the FDA-cleared S-Series OCT system and the investigational B-Series OCT with ImgAssist AI, aimed at enhancing surgical outcomes and addressing unmet medical needs.

U.S. Withdrawal from WHO: President Trump signed an executive order on January 20, 2025, to withdraw the U.S. from the World Health Organization, citing concerns over its governance, handling of the COVID-19 pandemic, and financial practices.
WHO's Response: The WHO expressed regret over the decision, highlighting the importance of U.S. involvement in global health initiatives and the historical partnership that has contributed to significant public health achievements.








